Geigy Chemical Corp. v. United States

54 Cust. Ct. 48, 1965 Cust. Ct. LEXIS 2596
CourtUnited States Customs Court
DecidedJanuary 19, 1965
DocketC.D. 2507
StatusPublished

This text of 54 Cust. Ct. 48 (Geigy Chemical Corp. v. United States) is published on Counsel Stack Legal Research, covering United States Customs Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Geigy Chemical Corp. v. United States, 54 Cust. Ct. 48, 1965 Cust. Ct. LEXIS 2596 (cusc 1965).

Opinion

Rao, Judge:

In the month of November 1959, plaintiff imported some 40,789 copies of a special supplement to a publication entitled “Canadian Psychiatric Association Journal.” This merchandise was classified by the collector of customs at the port of entry, as books, not specially provided for, within the purview of paragraph 1410 of the Tariff Act of 1930, as modified by the General Agreement on Tariffs and Trade, 82 Treas. Dec. 305, T.D. 51802, and supplemented by Presidential proclamation, 92 Treas. Dec. 175, T.D. 54399, and, accordingly, was assessed with duty at the rate of 9 per centum ad valorem.

It is the claim of plaintiff that said merchandise is entitled to entry without the payment of duty, by virtue of the provision in paragraph 1629(a) of the Tariff Act of 1930, as amended by T.D. 51908, for “publications of individuals for gratuitous private circulation, not advertising matter.”

The text of the provision invoked by the collector reads as follows:

Unbound books of all kinds, bound books of all kinds except those bound wholly or in part in leather, sheets or printed pages of books bound wholly or in part in leather, all the foregoing not specially provided for, if other than of bona fide foreign authorship (not including diaries, music in books, pamphlets, prayer books, sheets or printed pages of prayer books bound wholly or in part in leather, or tourist literature containing geographic, historical, hotel, timetable, travel, or similar information, chiefly with respect to places or travel facilities outside the continental United States).

[50]*50This case has been submitted for decision upon a written stipulation of counsel for the respective parties hereto, wherein and whereby a copy of said special supplement was offered in evidence as plaintiff’s exhibit 1, a commission duly executed by Dr. Frank Cyril Khodes Chalke was received in evidence as plaintiff’s exhibit 2, and the parties agreed that — ■

The product “Tofranil” frequently mentioned in this Special Supplement is produced by J. R. Geigy, S.A., Basle, Switzerland and sold and distributed by Geigy Chemical Corporation, New York, New York.

The testimony of Dr. Chalke, taken pursuant to said commission, permits the following summary:

Dr. Chalke, a professor of psychiatry at the University of Ottawa, is also the editor of the Canadian Psychiatric Association Journal, a publication which is the property of the Canadian Psychiatric Association. As editor, he is responsible for both the editorial and business management, although, in the latter capacity, his responsibility is shared with a committee.

Sometime in 1958, representatives of the Geigy corporation conferred with Dr. Chalke in Montreal regarding a conference to be held at McGill University, in the spring of 1959, on the subject of Depression and Allied States, and requested that the Canadian Psychiatric Association Journal consider publication of a special supplement carrying the proceedings of this conference.

It was agreed that the expense of publishing this special issue would be borne entirely by the Geigy corporation; that the editorial staff would have final say regarding the context and format of the presentation; that the journal would be distributed to all regular subscribers; and that the Geigy corporation could run as many additional copies of the special supplement as it required, for whatever use it chose to make of them, provided they were not offered for sale.

At that time, the journal was issued regularly four times a year, and the special supplement, which was published pursuant to the agreement of the parties, was a complementary addition to these regular issues. It contained the entire proceedings of the conference on Depression and Allied States, including all papers and deliberations, edited partly by the editorial staff of the journal, with Professor Ewen Cameron, professor of psychiatry, at McGill University, as guest editor.

The supplement was printed by a firm in Montreal, because the regular printers of the journal were unabel to cope with the large press run required for this special edition.

To the best of the knowledge of the witness, the special supplement was never sold or offered for sale. It was circulated by the Canadian [51]*51Psychiatric Association to its regular subscribers to the journal, and by the Geigy corporation, gratuitously, to physicians all over the world.

With reference to the statements on the second page of plaintiff’s exhibit 1, to the effect that the subscription for members is included in the annual Canadian Psychiatric Association membership fee, the subscription rate for nonmembers being $4 per annum, the witness stated that this statement is included in the regular masthead which appeared in all regular issues of the journal, and that gratuitous circulation among members was a condition for permitting the proceeding to be published as a special supplement to the journal.

Since the record shows that the special supplement here involved contains the full proceedings of the conference on Depression and Allied States, including all papers presented, and any discussions held thereon, counsel for plaintiff urges that the material is clearly educational, not advertising, despite the frequent references to plaintiff’s product Tofranil, and that, under the authority of the cases of Schieffelin et al. v. United States, 84 Fed. 880; United States v. Badische & Co., 8 Ct. Cust. Appls. 528, T.D. 33170; and United States v. Gips, 4 Ct. Cust. Appls. 458, T.D. 33879, plaintiff’s exhibit 1 was a publication gratuitously and privately circulated within the contemplation of paragraph 1629 (a), supra.

It is the primary contention of counsel for the Government that this special supplement was published and circulated for the purpose of advertising and exciting interest in plaintiff’s product, Tofranil, and to enhance the good will of the distributor. Under the circumstances, it is argued that the frequent references to Tofranil in the exhibit constitute advertising. It is further urged that the terms of the agreement did not restrict plaintiff to private distribution of the supplement, and that, since Tofranil is a prescription drug, physicians are the only group to which advertisement thereof can be directed, and, hence, that circulation amongst physicians is the equivalent of circulation to the general public itself. The cases of United States v. Silk Association of America, 16 Ct. Cust. Appls. 566, T.D. 43296, and United States v. American Railway Express Co. et al., 17 CCPA 10, T.D. 43317, are cited in support of the argument that the supplement contains advertising matter.

The statutory provision under which free entry of certain publications is permitted requires that such publications shall be those of individuals for gratuitous private circulation, not advertising matter. The last-mentioned phrase was first inserted in a corresponding provision in the Tariff Act of 1913, after the cases cited and relied upon by plaintiff herein had been decided. So, of course, they can have no bearing upon that phase of the instant inquiry which is concerned [52]*52with the question of what constitutes advertising matter. Nevertheless, they are of interest here for their discussions of the remaining portions of this provision which has otherwise been reenacted without change since 1894.

In the case of

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Gips
4 Ct. Cust. 458 (Customs and Patent Appeals, 1913)
Van Doorn v. United Statesq
12 Ct. Cust. 167 (Customs and Patent Appeals, 1924)
United States v. Silk Ass'n of America
16 Ct. Cust. 566 (Customs and Patent Appeals, 1929)
Schieffelin v. United States
84 F. 880 (Second Circuit, 1898)

Cite This Page — Counsel Stack

Bluebook (online)
54 Cust. Ct. 48, 1965 Cust. Ct. LEXIS 2596, Counsel Stack Legal Research, https://law.counselstack.com/opinion/geigy-chemical-corp-v-united-states-cusc-1965.